The Efficacy of Factor VIIa in Emergency Department Patients With Warfarin Use and Traumatic Intracranial Hemorrhage

被引:36
|
作者
Nishijima, Daniel K. [1 ]
Dager, William E. [2 ]
Schrot, Rudolph J. [3 ]
Holmes, James F. [1 ]
机构
[1] UC Davis, Sch Med, Dept Emergency Med, Davis, CA 95616 USA
[2] UC Davis, Sch Med, Dept Pharm, Davis, CA USA
[3] UC Davis, Sch Med, Dept Neurosurg, Davis, CA USA
关键词
factor VII; traumatic intracranial hemorrhage; warfarin; ACTIVATED FACTOR-VII; RECOMBINANT-FACTOR-VIIA; ACUTE INTRACEREBRAL HEMORRHAGE; INJURY SEVERITY SCORE; BRAIN-INJURY; DOUBLE-BLIND; ANTICOAGULANT-THERAPY; CLINICAL-TRIAL; HEAD-INJURIES; REVERSAL;
D O I
10.1111/j.1553-2712.2010.00666.x
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: The objective was to compare outcomes in emergency department (ED) patients with preinjury warfarin use and traumatic intracranial hemorrhage (tICH) who did and did not receive recombinant activated factor VIIa (rFVIIa) for international normalized ratio (INR) reversal. Methods: This was a retrospective before-and-after study conducted at a Level 1 trauma center, with data from 1999 to 2009. Eligible patients had preinjury warfarin use and tICH on cranial computed tomography (CT) scan. Patients before (standard cohort) and after (rFVIIa cohort) implementation of a protocol for administering 1.2 mg of rFVIIa in the ED were reviewed. Glasgow Coma Scale (GCS) score, Revised Trauma Score (RTS), Injury Severity Score (ISS), INR, and Marshall score were collected. Outcome measures included mortality, thromboembolic complications, and INR normalization. Results: Forty patients (median age = 80.5 years, interquartile range [IQR] = 63.5-85) were included (20 in each cohort). Age, GCS score, ISS, RTS, initial INR, and Marshall score were similar (p > 0.05) between the two cohorts. Survival was identical between cohorts (13 of 20, or 65.0%, 95% confidence interval [CI] = 40.8% to 84.6%). There were no differences in rate of thromboembolic complications in the standard cohort (1 of 20, 5.0%, 95% CI = 0.1% to 24.9%) than the rFVIIa cohort (4 of 20, 20.0%, 95% CI = 5.7% to 43.7%; p = 0.34). Time to normal INR was earlier in the rFVIIa cohort (mean = 4.8 hours, 95% CI = 3.0 to 6.7 hours) than in the standard cohort (mean = 17.5 hours, 95% CI = 12.5 to 22.6; p < 0.001). Conclusions: In patients with preinjury warfarin and tICH, use of rFVIIa was associated with a decreased time to normal INR. However, no difference in mortality was identified. Use of rFVIIa in patients on warfarin and tICH requires further study to demonstrate important patient-oriented outcomes. ACADEMIC EMERGENCY MEDICINE 2010; 17:244-251 (C) 2010 by the Society for Academic Emergency Medicine.
引用
收藏
页码:244 / 251
页数:8
相关论文
共 50 条
  • [31] Assessing the Efficacy of Platelet Transfusion for Patients with Traumatic Intracranial Hemorrhage
    Doberstein, Cody A.
    Powers, Andrew Y.
    Pinto, Mauricio B.
    Tang, Oliver Y.
    Chen, Jia-Shu
    Asaad, Wael F.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2018, 227 (04) : S186 - S186
  • [32] Management of Warfarin Associated Intracranial Hemorrhage with a 3-Factor Prothrombin Complex Concentrate and Low Dose Recombinant Factor VIIa
    Matevosyan, Karen
    Madden, Christopher
    Aung, Fleur M.
    Chason, David P.
    Arbique, Garry
    Guild, Jeffrey
    Shafi, Shahid
    Sarode, Ravindra
    BLOOD, 2008, 112 (11) : 1165 - 1166
  • [33] Reversal of Warfarin-Induced Hemorrhage in the Emergency Department
    Zareh, Meena
    Davis, Andrew
    Henderson, Sean
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2011, 12 (04) : 386 - 392
  • [34] An epidemiology of spontaneous intracranial hemorrhage patients presenting to the emergency department in Qatar
    Bhutta, Z. A.
    Dsouza, L. B.
    Matt, I. B.
    Mohammed, R.
    Bhutta, R. A.
    Pathan, S. A.
    Thomas, S. H.
    CEREBROVASCULAR DISEASES, 2018, 45 : 124 - 124
  • [35] Characteristics and Outcomes of Intracranial Hemorrhage in Cancer Patients Visiting the Emergency Department
    Qdaisat, Aiham
    Yeung, Sai-Ching J.
    Rojas Hernandez, Cristhiam H.
    Samudrala, Pavani
    Kamal, Mona
    Li, Ziyi
    Wechsler, Adriana H.
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (03)
  • [36] Use of factor IX complex in warfarin-related intracranial hemorrhage - Comment
    Mathiesen, T
    NEUROSURGERY, 1999, 45 (05) : 1118 - 1119
  • [37] Rapid warfarin reversal in anticoagulated patients with traumatic intracranial hemorrhage reduces hemorrhage progression and mortality - Discussion
    Waxman, KS
    Lucas, C
    Screiber, M
    Foreman, ML
    Janczyk, RJ
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2005, 59 (05): : 1137 - 1139
  • [38] Risk factors for traumatic intracranial hemorrhage in mild traumatic brain injury patients at the emergency department: a systematic review and meta-analysis
    Yang, Li Jin
    Lassaren, Philipp
    Londi, Filippo
    Palazzo, Leonardo
    Fletcher-Sandersjoo, Alexander
    Angeby, Kristian
    Thelin, Eric Peter
    Rubenson Wahlin, Rebecka
    SCANDINAVIAN JOURNAL OF TRAUMA RESUSCITATION & EMERGENCY MEDICINE, 2024, 32 (01):
  • [39] Warfarin Use Prompting Significant Intervention in the Emergency Department: Acute Hemorrhage and Bleeding Concerns
    Pollack, Charles, V
    Peacock, W. Frank
    Frost, Alex
    Silber, Steven H.
    Bernstein, Richard A.
    Merli, Geno
    Jahromi, Babak S.
    Douketis, James D.
    Villines, Todd C.
    Fermann, Greg
    Fiore, Gregory J.
    Fanikos, John
    CIRCULATION, 2018, 138
  • [40] Newer and Better? Comparing Direct Oral Anticoagulants to Warfarin in Patients With Traumatic Intracranial Hemorrhage
    Billings, Joshua D.
    Khan, Abid D.
    McVicker, John H.
    Schroeppel, Thomas J.
    AMERICAN SURGEON, 2020, 86 (09) : 1062 - 1066